• About
  • Technology
  • Roadmap
  • Partner
  • Invest
  • News
  • Contact Us
Genlumina Founded in Leiden: Pioneering Cancer Treatment with Light-Activated Drugs

Genlumina Founded in Leiden: Pioneering Cancer Treatment with Light-Activated Drugs

by admin | Nov 26, 2024 | News

Leiden, October 25, 2024 – Genlumina, a biotech startup dedicated to transforming cancer treatment through light-activated drugs, was officially founded in Leiden on August 13, 2024. The founding team includes Donny de Bruin (Chief Scientific Officer and Operations...

Recent Posts

  • New Step in Targeted Cancer Therapy
  • Genlumina Awarded MIT Grant for ‘Silver Bullet’ Feasibility Study
  • UNIIQ invests in GenLumina
  • Jobs: Laboratory Technician
  • Invest €100K to elimate cancer cell by cell with a new drug activated by light

Recent Comments

No comments to show.

Whether you’re a researcher, healthcare professional, or investor, we invite you to be part of the future of cancer treatment. Together, we can make precision care a reality for every patient.

About Us
➊
Technology
➋
Product
➌
Roadmap
➍

Investor Opportunities

Partner Opportunities

GenLumina

About us
Technology
Roadmap
News

Visit us

Langegracht 70
2312 NV Leiden
The Netherlands

Contact us

www.GenLumina.com/contact

Follow us